Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Opsens Inc T.OPS

Alternate Symbol(s):  OPSSF

OpSens Inc. is engaged in physiological measurements such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and in transcatheter aortic valve replacement (TAVR) in the structural heart market. The Company supplies an optical-based pressure guidewire (OptoWire), a guidewire used in the TAVR procedure (SavvyWire) and a wide range of miniature optical sensors to measure pressure and temperature to be used in a wide range of applications that can be integrated into other medical devices.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

RE:Something is cooking for sure !

Love the action today on solid volume . GLTA   rate and reply

Something is cooking for sure !

But not the ''carrots'' Expectation is growing but look to me a bit too soon. The leap will be stronger !  rate and reply

RE:Pretty interesting ''Chart''

I agree! And volume is better on CDN and US exchanges. It smells good!!! GLTA  rate and reply

Pretty interesting ''Chart''

Mimi break and higher than third week of April when Health Canada OK '' NEW TAVR GUIDEWIRE' Stock price is already pointing to FDA approval sometimes in September-October OPS more

Bientot $2,30

Il est encore reparti vers $2,30. Tres instable, pas assez de volume  rate and reply

TD Conference Call Participant

I sent an email to Jeffrey Schacter,the TD analyst who was participating in the conference call.I asked him if he was planning to publish a research about Opsens on the WebBroker site. He will more

RE:A game changer....FDA approval

Added a few more yesterday on the dip. GLTA  rate and reply

A game changer....FDA approval

From the last CC: ''n regards to the FDA clearance, since the last call, we had a Q-Sub meeting with the FDA to discuss our proposed answers on last questions remaining. The Q-Sub more

Slow and Steady

We could use more trading volume but we are slowly and surely heading in the right direction. And since this week began, it's beginning to look like markets may have bottomed. GLTA  rate and reply

Strong buy on

Technical indicators strong!  rate and reply

Bid only on NEO... no ask! Looking good!!/market-depth  rate and reply

Raymond James - cantechletter

We’re still bullish on Opsens, says Raymond James By Nick Waddell Published on July 18, 2022 Last Updated on July 18, 2022 Filed under:   All posts, more

RE:RE:RE:RE:RE:Conference call

And yet despite this excellent CC, we're one of the few companies in the red this morning. Clearly it reinforces the old saying that "the market can remain irrational longer than the more

About the CC and comments from analysts

in summary a Great Conference Conference Call Participants                 Comments Rahul Sarugaser - Raymond James Ltd.  Very well done Congrats more

RE:RE:RE:RE:Conference call

No sign of any report from TD but their participation in the CC may indicate that they are considering initiating coverage. GLTA  rate and reply

RE:RE:RE:Conference call

A good read. As everyone could see, we had analysts from six firms. The current targets I have from these firms are $3.35 (Stifel), $4.00 (RBC and MPartners), $4.10 (Paradigm) and $6.00 (Raymond more

RE:RE:Conference call

Thank you for posting the written form of the conference call. It's way easier to comprehend everything that was said.  rate and reply

RE:Conference call

Analysts seemed interested IMO Opsens Inc. (OPSSF) CEO Louis Laflamme more

Conference call

In the question period at the conference call Mister Louis Laflamme said that there is two questions that the FDA want answers . The first one refers to Bio compatibility of the product. To that more